AHR and ovarian serous carcinoma: For the first time, the dysfunctional AHR binding pathway accompanied with 10 corresponding DEGs was found significantly to be participated in tumorigenesis of both serous BOT and serous ovarian carcinoma and five vital biomarkers related to EMT were searched and gathered for this analytic study.